2022 influenza vaccines
The TGA has announced the composition of the 2022 seasonal influenza vaccines. Compared with the 2021 quadrivalent vaccines, the 2022 vaccines contain a new A (H3N2)-like virus strain and a new B Victoria-like virus strain. The egg-based quadrivalent influenza vaccines contain an A/Victoria/2570/2019 (H1N1)pdm09-like virus; an A/Darwin/9/2021 (H3N2)-like virus; a B/Austria/1359417/2021-like (B/Victoria lineage) virus; and a B/Phuket/ 3073/2013 (B/Yamagata lineage)-like virus. The cell-based quadrivalent influenza vaccines contain an A/Wisconsin/588/2019 (H1N1)pdm09-like virus; an A/Darwin/6/2021 (H3N2)-like virus; a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.
Epilepsy in Australia
Aboriginal and Torres Strait Islander people are twice as likely as non-Indigenous people to have epilepsy and 3.5 times more likely to have an epilepsy-related hospitalisation, according to a new report from the Australian Institute of Health and Welfare. Epilepsy in Australia notes that about 151,000 people in Australia have epilepsy, with more than 31,000 hospital admissions associated with epilepsy occurring in 2018–19. Rates of hospitalisation were 1.3 times higher in very remote areas compared with major cities and 1.8 times higher in those living in the lowest socioeconomic areas compared with those living in the highest. Read the report via: https://www.aihw.gov.au/reports.